Matrix control of pancreatic cancer: new insights into fibronectin signaling

Por Topalovski, Mary, Brekken, Rolf A.
Publicado no Cancer Lett (2015)

Hypoxia and Transforming Growth Factor β Cooperate to Induce Fibulin-5 Expression in Pancreatic Cancer

Por Topalovski, Mary, Hagopian, Michelle, Wang, Miao, Brekken, Rolf A.
Publicado no J Biol Chem (2016)

Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis

Por Ostapoff, Katherine T., Cenik, Bercin Kutluk, Wang, Miao, Ye, Risheng, Xu, Xiaohong, Nugent, Desiree, Hagopian, Moriah M., Topalovski, Mary, Rivera, Lee B., Carroll, Kyla D., Brekken, Rolf A.
Publicado em 2014

Fibulin-5 blocks microenvironmental ROS in pancreatic cancer

Por Wang, Miao, Topalovski, Mary, Toombs, Jason E., Wright, Christopher M., Moore, Zachary R., Boothman, David A., Yanagisawa, Hiromi, Wang, Huamin, Witkiewicz, Agnieszka, Castrillon, Diego H., Brekken, Rolf A.
Publicado no Cancer Res (2015)

Small molecule inhibition of Axl targets tumor immune suppression and enhances chemotherapy in pancreatic cancer

Por Ludwig, Kathleen F., Du, Wenting, Sorrelle, Noah B., Wnuk-Lipinska, Katarzyna, Topalovski, Mary, Toombs, Jason E., Cruz, Victoria H., Yabuuchi, Shinichi, Rajeshkumar, N.V., Maitra, Anirban, Lorens, James B., Brekken, Rolf A.
Publicado no Cancer Res (2017)